FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051289134> ?p ?o ?g. }

• W2051289134 endingPage "699" @default.
• W2051289134 startingPage "685" @default.
• W2051289134 abstract "1 The effects of endothelin-1 and of three analogues in which alanyl residues had been substituted in place of cysteinyl residues were studied in the rat, isolated, Krebs-Henseleit-perfused mesenteric bed and the in situ, blood-perfused, mesenteric and hindquarters circulations of the rat. The effects on the vascular responses to these peptides of removing the endothelium by detergent perfusion or of cyclo-oxygenase inhibition by indomethacin were also determined. 2 In all three preparations, endothelin-1 was a potent vasoconstrictor (ED50 values ranged from 40 to 400 pmol) although it was rather less potent in the hindquarters than in the mesentery. Also, the maximum response was very much smaller in the isolated mesentery (24.7 ± 2.1 mmHg) than in the in situ mesentery (81.8 ± 2.6 mmHg) or hindquarters (107 ± 10 mmHg). 3 Removal of the endothelium by perfusion with detergent significantly enhanced the potency of endothelin as a vasoconstrictor in the in situ messentery, but reduced the maximum response obtained, whereas removal of the endothelium in vitro significantly increased the maximum response without changing the ED50. The presence or absence of indomethacin had no significant effects in the blood-perfused hindquarters preparation or the isolated mesentery but, after administration of 5 mg kg−1 indomethacin to the in situ mesenteric preparation, the maximal response to endothelin-1 was enhanced. 4 When the preparations were preconstricted with α1-adrenoceptor agonists, endothelin-1 had modest vasodilator effects. These vasodilator effects were abolished when the endothelium was destroyed by detergent perfusion. 5 Both [Ala3,11]endothelin-1 and [Ala1,15]endothelin-1 were also vasoconstrictor agents in the mesenteric preparations but they were less potent than endothelin-1 itself; [Ala3,11]endothelin-l was intermediate in potency between endothelin-1 and [Ala1,15]endothelin-1. In the in situ preparation these analogues gave similar maximal responses to the parent peptide but, in vitro, they gave maximal responses that were much greater than that of endothelin-1 and which were similar to those found with all 3 peptides in the in situ mesentery. Destruction of the endothelium in vitro had no effect on the responses to these 2 analogues and the log dose-response curve for [Ala1,15]endothelin-l in the isolated mesentery was biphasic. 6 A third analogue possessing no disulphide bridges ([Ala1,3,11,15]endothelin-l) was a partial agonist in the in situ preparations but had no vasoconstrictor effect in the in vitro mesentery. It had no vasorelaxant effect in the hindquarters preparation but it enhanced the responses to endothelin-1 when the 2 peptides were administered together in all 3 preparations. 7 It is concluded that it is not essential for the endothelin family of peptides to possess 2 disulphide bridges for them to be vasoconstrictor agents. However, only endothelin-1, of the 4 peptides studied, showed either endothelium-dependent vasorelaxant activity or modulation by the endothelium of its pressor effects. This, together with some differences in the vasoconstrictor log dose-response curves to the peptides and the results of co-administration of [Ala1,31115]endothelin-1 and endothelin-1, suggests that there may be more than one receptor type mediating vascular responses to the peptides studied." @default.
• W2051289134 created "2016-06-24" @default.
• W2051289134 creator A5013412756 @default.
• W2051289134 creator A5052987962 @default.
• W2051289134 creator A5070464366 @default.
• W2051289134 date "1989-10-01" @default.
• W2051289134 modified "2023-10-14" @default.
• W2051289134 title "Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat" @default.
• W2051289134 cites W1969712064 @default.
• W2051289134 cites W1970381527 @default.
• W2051289134 cites W1973929461 @default.
• W2051289134 cites W1980762198 @default.
• W2051289134 cites W1982462955 @default.
• W2051289134 cites W1982697546 @default.
• W2051289134 cites W1990386820 @default.
• W2051289134 cites W1991915535 @default.
• W2051289134 cites W1997987554 @default.
• W2051289134 cites W2003147778 @default.
• W2051289134 cites W2006321590 @default.
• W2051289134 cites W2006495041 @default.
• W2051289134 cites W2008079735 @default.
• W2051289134 cites W2011348280 @default.
• W2051289134 cites W2011415422 @default.
• W2051289134 cites W2012503408 @default.
• W2051289134 cites W2014029891 @default.
• W2051289134 cites W2014829207 @default.
• W2051289134 cites W2019341452 @default.
• W2051289134 cites W2029783647 @default.
• W2051289134 cites W2033616744 @default.
• W2051289134 cites W2040721821 @default.
• W2051289134 cites W2052490987 @default.
• W2051289134 cites W2058685821 @default.
• W2051289134 cites W2060873399 @default.
• W2051289134 cites W2061351333 @default.
• W2051289134 cites W2062372284 @default.
• W2051289134 cites W2079708404 @default.
• W2051289134 cites W2080182312 @default.
• W2051289134 cites W2084761390 @default.
• W2051289134 cites W2104840130 @default.
• W2051289134 cites W2162804111 @default.
• W2051289134 doi "https://doi.org/10.1111/j.1476-5381.1989.tb12644.x" @default.
• W2051289134 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1854732" @default.
• W2051289134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2684315" @default.
• W2051289134 hasPublicationYear "1989" @default.
• W2051289134 type Work @default.
• W2051289134 sameAs 2051289134 @default.
• W2051289134 citedByCount "94" @default.
• W2051289134 countsByYear W20512891342012 @default.
• W2051289134 countsByYear W20512891342014 @default.
• W2051289134 countsByYear W20512891342016 @default.
• W2051289134 countsByYear W20512891342017 @default.
• W2051289134 crossrefType "journal-article" @default.
• W2051289134 hasAuthorship W2051289134A5013412756 @default.
• W2051289134 hasAuthorship W2051289134A5052987962 @default.
• W2051289134 hasAuthorship W2051289134A5070464366 @default.
• W2051289134 hasBestOaLocation W20512891342 @default.
• W2051289134 hasConcept C105702510 @default.
• W2051289134 hasConcept C120770815 @default.
• W2051289134 hasConcept C126322002 @default.
• W2051289134 hasConcept C134018914 @default.
• W2051289134 hasConcept C144980905 @default.
• W2051289134 hasConcept C146957229 @default.
• W2051289134 hasConcept C149601957 @default.
• W2051289134 hasConcept C170493617 @default.
• W2051289134 hasConcept C185592680 @default.
• W2051289134 hasConcept C202751555 @default.
• W2051289134 hasConcept C2776820930 @default.
• W2051289134 hasConcept C2776992346 @default.
• W2051289134 hasConcept C2777663904 @default.
• W2051289134 hasConcept C2778948390 @default.
• W2051289134 hasConcept C2779961880 @default.
• W2051289134 hasConcept C2780771799 @default.
• W2051289134 hasConcept C2909649922 @default.
• W2051289134 hasConcept C42533223 @default.
• W2051289134 hasConcept C55493867 @default.
• W2051289134 hasConcept C57992300 @default.
• W2051289134 hasConcept C71924100 @default.
• W2051289134 hasConcept C86803240 @default.
• W2051289134 hasConcept C98274493 @default.
• W2051289134 hasConceptScore W2051289134C105702510 @default.
• W2051289134 hasConceptScore W2051289134C120770815 @default.
• W2051289134 hasConceptScore W2051289134C126322002 @default.
• W2051289134 hasConceptScore W2051289134C134018914 @default.
• W2051289134 hasConceptScore W2051289134C144980905 @default.
• W2051289134 hasConceptScore W2051289134C146957229 @default.
• W2051289134 hasConceptScore W2051289134C149601957 @default.
• W2051289134 hasConceptScore W2051289134C170493617 @default.
• W2051289134 hasConceptScore W2051289134C185592680 @default.
• W2051289134 hasConceptScore W2051289134C202751555 @default.
• W2051289134 hasConceptScore W2051289134C2776820930 @default.
• W2051289134 hasConceptScore W2051289134C2776992346 @default.
• W2051289134 hasConceptScore W2051289134C2777663904 @default.
• W2051289134 hasConceptScore W2051289134C2778948390 @default.
• W2051289134 hasConceptScore W2051289134C2779961880 @default.
• W2051289134 hasConceptScore W2051289134C2780771799 @default.
• W2051289134 hasConceptScore W2051289134C2909649922 @default.
• W2051289134 hasConceptScore W2051289134C42533223 @default.
• W2051289134 hasConceptScore W2051289134C55493867 @default.

• next